![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Ai‐Ming Yu, Mei‐Juan Tu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107967-107967
Open Access | Times Cited: 64
Ai‐Ming Yu, Mei‐Juan Tu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107967-107967
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Gavin M. Traber, Ai‐Ming Yu
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 133-154
Open Access | Times Cited: 146
Gavin M. Traber, Ai‐Ming Yu
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 133-154
Open Access | Times Cited: 146
tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
The nexus between RNA-binding proteins and their effectors
Shiyang He, Eugene Valkov, Sihem Cheloufi, et al.
Nature Reviews Genetics (2022) Vol. 24, Iss. 5, pp. 276-294
Open Access | Times Cited: 47
Shiyang He, Eugene Valkov, Sihem Cheloufi, et al.
Nature Reviews Genetics (2022) Vol. 24, Iss. 5, pp. 276-294
Open Access | Times Cited: 47
Multistage-Responsive Nanocomplexes Attenuate Ulcerative Colitis by Improving the Accumulation and Distribution of Oral Nucleic Acid Drugs in the Colon
Xiaoxin Li, Yanyan Yang, Zhibin Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 1, pp. 2058-2070
Closed Access | Times Cited: 35
Xiaoxin Li, Yanyan Yang, Zhibin Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 1, pp. 2058-2070
Closed Access | Times Cited: 35
Rational design and combinatorial chemistry of ionizable lipids for RNA delivery
Yue Xu, Alex Golubovic, Shufen Xu, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 28, pp. 6527-6539
Closed Access | Times Cited: 23
Yue Xu, Alex Golubovic, Shufen Xu, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 28, pp. 6527-6539
Closed Access | Times Cited: 23
The Growing Class of Novel RNAi Therapeutics
Gavin M. Traber, Ai‐Ming Yu
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 13-20
Open Access | Times Cited: 10
Gavin M. Traber, Ai‐Ming Yu
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 13-20
Open Access | Times Cited: 10
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents
Gavin M. Traber, Colleen Yi, Neelu Batra, et al.
RNA (2024), pp. rna.079904.123-rna.079904.123
Open Access | Times Cited: 6
Gavin M. Traber, Colleen Yi, Neelu Batra, et al.
RNA (2024), pp. rna.079904.123-rna.079904.123
Open Access | Times Cited: 6
Nucleophilic Reactions of Phosphorothioate Oligonucleotides
Jin Jin, Cheng Tian, Chunfa Chen, et al.
Small Methods (2025)
Closed Access
Jin Jin, Cheng Tian, Chunfa Chen, et al.
Small Methods (2025)
Closed Access
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 45
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 45
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
Denisa Bojková, Rui Costa, Philipp Reus, et al.
Metabolites (2021) Vol. 11, Iss. 10, pp. 699-699
Open Access | Times Cited: 40
Denisa Bojková, Rui Costa, Philipp Reus, et al.
Metabolites (2021) Vol. 11, Iss. 10, pp. 699-699
Open Access | Times Cited: 40
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 5
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 5
Research progress on non-protein-targeted drugs for cancer therapy
Yiwen Zhang, Lu Lu, Feifeng Song, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Yiwen Zhang, Lu Lu, Feifeng Song, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 11
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 11
Types of RNA therapeutics
Pouya Goleij, Mehregan Babamohamadi, Aryan Rezaee, et al.
Progress in molecular biology and translational science (2024), pp. 41-63
Closed Access | Times Cited: 3
Pouya Goleij, Mehregan Babamohamadi, Aryan Rezaee, et al.
Progress in molecular biology and translational science (2024), pp. 41-63
Closed Access | Times Cited: 3
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 20
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 20
Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression
Linwen Zeng, Shaofeng Yuan, Pengfei Zhou, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11795-11810
Open Access | Times Cited: 25
Linwen Zeng, Shaofeng Yuan, Pengfei Zhou, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11795-11810
Open Access | Times Cited: 25
The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
Lei Zhang, Yayu Liang, Guohui Liang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Lei Zhang, Yayu Liang, Guohui Liang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Delivery of nucleic acids using nanomaterials
Yuyang Qin, Liyuan Ou, Lili Zha, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 8
Yuyang Qin, Liyuan Ou, Lili Zha, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 8
Binding Mechanism of Riboswitch to Natural Ligand Elucidated by McMD-Based Dynamic Docking Simulations
Gert‐Jan Bekker, Yoshifumi Fukunishi, Junichi Higo, et al.
ACS Omega (2024)
Open Access | Times Cited: 2
Gert‐Jan Bekker, Yoshifumi Fukunishi, Junichi Higo, et al.
ACS Omega (2024)
Open Access | Times Cited: 2
Development, Validation and Application of an Ion-Pair Reversed-Phase Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Nusinersen
Xiao Zhang, Chunjie Sha, Wei Zhang, et al.
Bioanalysis (2024) Vol. 16, Iss. 5, pp. 305-317
Closed Access | Times Cited: 2
Xiao Zhang, Chunjie Sha, Wei Zhang, et al.
Bioanalysis (2024) Vol. 16, Iss. 5, pp. 305-317
Closed Access | Times Cited: 2
Molecular Engineering of Functional SiRNA Agents
Neelu Batra, Mei‐Juan Tu, Ai‐Ming Yu
ACS Synthetic Biology (2024) Vol. 13, Iss. 6, pp. 1906-1915
Open Access | Times Cited: 2
Neelu Batra, Mei‐Juan Tu, Ai‐Ming Yu
ACS Synthetic Biology (2024) Vol. 13, Iss. 6, pp. 1906-1915
Open Access | Times Cited: 2
Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs
Yimei Wang, Mei‐Juan Tu, Ai‐Ming Yu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Yimei Wang, Mei‐Juan Tu, Ai‐Ming Yu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research
Joseph M. Cronin, Ai‐Ming Yu
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 6, pp. 685-699
Open Access | Times Cited: 7
Joseph M. Cronin, Ai‐Ming Yu
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 6, pp. 685-699
Open Access | Times Cited: 7
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
Yixin Chen, Mei‐Juan Tu, Fangwei Han, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4273-4290
Open Access | Times Cited: 7
Yixin Chen, Mei‐Juan Tu, Fangwei Han, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4273-4290
Open Access | Times Cited: 7
A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)
Alejandra González‐Duarte, Alfredo Ulloa‐Aguirre
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13158-13158
Open Access | Times Cited: 19
Alejandra González‐Duarte, Alfredo Ulloa‐Aguirre
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13158-13158
Open Access | Times Cited: 19